About The Journal of Invasive Fungal Infections

Editorial Policy

The Journal of Invasive Fungal Infections is an independent journal published by Remedica Medical Education and Publishing Ltd. The aim is to provide an up-to-date overview of the recent literature compiled by an international team of practising physicians. Leading articles commissioned by the Editor-in-Chief review new therapeutic techniques and emerging technologies, and news from major international meetings is reported. Editorial control is vested entirely in the Editor-in-Chief, Editors, and Editorial Advisory Board.

Remedica Medical Education and Publishing Ltd., 1 New Oxford Street, London, WC1A 1NU, UK.
Telephone: +44 (0)20 7759 2999 Fax: +44 (0)20 7759 2951
Email: info@remedicajournals.com

Editor: Simon Worsley
Editorial Director: Scott Millar
Production Team: Mary Hughes, Rabiha Sharif
Design and Artwork: AS&K Skylight Creative Services
Publishers: Ian Ackland-Snow, Simon Kirsch

ISSN 1753-3783 (Print)
ISSN 2040-3917 (Online)

Publisher’s Statement
© Remedica Medical Education and Publishing 2007-2012. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the copyright owners. Articles published here may have previously been published in The International Journal of Clinical Reviews, www.ijocr.com. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers and any sponsoring company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the Physicians Circular issued by the manufacturer.


Fungal 1
What do you consider to be the most common cause of biofilm growth when using an intravenous catheter?

Powered by NetPolls